ArticleDermatology and therapy2026

Treatment Patterns, Drug Survival, and Effectiveness of Tildrakizumab Among Patients with Prior Interleukin-17 Experience in the PPD CorEvitas Psoriasis Registry.

Mark G Lebwohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.